STERIS plcSTE
What STERIS plc does.
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room (“OR”) integrati on.
We operate and report our financial information in three reportable business segments: Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences. Previously, we had four reportable business segments; however, as a result of the fiscal 2025 divestiture of our Dental segment, Dental is presented as discontinued operations. Historical information has been retrospectively adjusted to exclude discontinued operations for comparability, as required. For more information, refer to Note 4 to our consolidated financial statements titled, "Discontinued Operations." Non-allocated operating costs that support the entire Company and items not indicative of operating trends are excluded from segment operating income. We describe our business segments in the section that follows, titled "Information Related to Business Segments" and Note 13 to our consolidated financial statements titled, "Business Segment Information."
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B |
| Net income | $397.4M | $243.9M | $107.0M | $378.2M | $614.6M | $782.3M |
| Free cash flow | $450.4M | $397.2M | $395.0M | $613.0M | $778.0M | $972.4M |
More on STE.
- STERIS plc summary
- STERIS plc financial statements
- STERIS plc key metrics
- STERIS plc health scores and style box
- STERIS plc earnings
- STERIS plc dividends
- STERIS plc valuation
- STERIS plc ownership and insiders
- STERIS plc peers
Figures from STERIS plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.